Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001719091 | SCV000729256 | likely benign | not provided | 2023-03-13 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003987621 | SCV004803424 | uncertain significance | not specified | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004025003 | SCV005029067 | uncertain significance | Cardiovascular phenotype | 2024-03-05 | criteria provided, single submitter | clinical testing | The c.-4C>G variant is located in the 5' untranslated region (5’ UTR) of the MAP2K2 gene. This variant results from a C to G substitution 4 bases upstream from the first translated codon. This nucleotide position is highly conserved in available vertebrate species. Based on the available evidence, the clinical significance of this alteration remains unclear. |